Clinical trial No longer in our active list Observational Ages 18 to 80

Exploring the genetic causes of mitral valve prolapse

Official title: Genetic Basis of Mitral Valve Prolapse

Run by Massachusetts General Hospital · NCT01719211 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to find out if certain genes are linked to mitral valve prolapse by looking at DNA from families who have a history of the condition.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment1500 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
Trial IDNCT01719211 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with mitral valve prolapse.

Probably not a fit

Patients with other mitral valve diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify genetic factors associated with mitral valve prolapse (MVP) by recruiting large families with a history of the condition and collecting DNA samples from 1,000-1,500 affected individuals. The researchers have already pinpointed two novel genetic loci on chromosomes 11 and 13 and are investigating altered genes in these regions. By conducting a genome-wide association study, the goal is to uncover the genes responsible for MVP, which could enhance understanding and treatment of the disease.

Why it matters

Potential benefit: If successful, this study could lead to better prevention and treatment strategies for individuals genetically predisposed to mitral valve prolapse.

How similar studies have gone: Other studies have shown success in identifying genetic factors related to cardiovascular conditions, suggesting potential for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mitral valve prolapse

Exclusion Criteria:

* Other mitral valve diseases

Where it's running

  • Mass General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.